At the leading edge of innovation, HORIBA Medical’s products are internationally recognized.
Its flexible production facilities and innovative R&D are major assets that allow it to develop solutions that meet market demand and the particular needs of its customers.
Its Hematology expertise has earned Horiba Medical a reputation among the biggest specialists of in vitro diagnostics.

Key indicators

  • Over 1,100 employees
  • 4 production centers (Japan, China, France, Brazil)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 13 local/direct operations
  • Around 30,000 laboratories supplied worldwide

14 Feb 2019 - EuroMedLab 2019

14 Feb 2019 - 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine

Read more

6 Feb 2019 - HORIBA Medical Brings Malaria Screening in Routine Hematology

6 Feb 2019 - Based on innovative ‘data mining’ techniques and combined with Full Blood Count, the Malaria...

Read more

6 Feb 2019 - HORIBA Medical launches their new parameter, Yumizen D-Dimer, for deep vein thrombosis and pulmonary embolism diagnosis on the Yumizen G Hemostasis range

6 Feb 2019 - HORIBA Medical announces the availability of a D-Dimer reagent for their semi-automated Hemostasis...

Read more